99 related articles for article (PubMed ID: 12687018)
1. Ligand-activated Ahr signaling leads to disruption of nephrogenesis and altered Wilms' tumor suppressor mRNA splicing.
Falahatpisheh MH; Ramos KS
Oncogene; 2003 Apr; 22(14):2160-71. PubMed ID: 12687018
[TBL] [Abstract][Full Text] [Related]
2. Genetic regulatory networks of nephrogenesis: deregulation of WT1 splicing by benzo(a)pyrene.
Ramos KS; Nanez A
Birth Defects Res C Embryo Today; 2009 Jun; 87(2):192-7. PubMed ID: 19530133
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional profiling and functional genomics reveal a role for AHR transcription factor in nephrogenesis.
Ramos KS
Ann N Y Acad Sci; 2006 Sep; 1076():728-35. PubMed ID: 17119250
[TBL] [Abstract][Full Text] [Related]
4. A mutant Ahr allele protects the embryonic kidney from hydrocarbon-induced deficits in fetal programming.
Nanez A; Ramos IN; Ramos KS
Environ Health Perspect; 2011 Dec; 119(12):1745-53. PubMed ID: 21803694
[TBL] [Abstract][Full Text] [Related]
5. Developmental expression of two members of a new class of transcription factors: I. Expression of aryl hydrocarbon receptor in the C57BL/6N mouse embryo.
Abbott BD; Birnbaum LS; Perdew GH
Dev Dyn; 1995 Oct; 204(2):133-43. PubMed ID: 8589437
[TBL] [Abstract][Full Text] [Related]
6. AHR regulates WT1 genetic programming during murine nephrogenesis.
Falahatpisheh MH; Nanez A; Ramos KS
Mol Med; 2011; 17(11-12):1275-84. PubMed ID: 21863216
[TBL] [Abstract][Full Text] [Related]
7. The major podocyte protein nephrin is transcriptionally activated by the Wilms' tumor suppressor WT1.
Wagner N; Wagner KD; Xing Y; Scholz H; Schedl A
J Am Soc Nephrol; 2004 Dec; 15(12):3044-51. PubMed ID: 15579507
[TBL] [Abstract][Full Text] [Related]
8. A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system.
Wagner N; Wagner KD; Hammes A; Kirschner KM; Vidal VP; Schedl A; Scholz H
Development; 2005 Mar; 132(6):1327-36. PubMed ID: 15716344
[TBL] [Abstract][Full Text] [Related]
9. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
10. Angioblast-mesenchyme induction of early kidney development is mediated by Wt1 and Vegfa.
Gao X; Chen X; Taglienti M; Rumballe B; Little MH; Kreidberg JA
Development; 2005 Dec; 132(24):5437-49. PubMed ID: 16291795
[TBL] [Abstract][Full Text] [Related]
11. Modulation of biological regulatory networks during nephrogenesis.
Ramos KS; Hadi Falahatpisheh M; Nanez A; He Q
Drug Metab Rev; 2006; 38(4):677-83. PubMed ID: 17145695
[TBL] [Abstract][Full Text] [Related]
12. The ratio of +/-KTS splice variants of the Wilms' tumour suppressor protein WT1 mRNA is determined by an intronic enhancer.
Yang C; Romaniuk PJ
Biochem Cell Biol; 2008 Aug; 86(4):312-21. PubMed ID: 18756326
[TBL] [Abstract][Full Text] [Related]
13. Expression of Wilms' tumor suppressor in the liver with cirrhosis: relation to hepatocyte nuclear factor 4 and hepatocellular function.
Berasain C; Herrero JI; García-Trevijano ER; Avila MA; Esteban JI; Mato JM; Prieto J
Hepatology; 2003 Jul; 38(1):148-57. PubMed ID: 12829997
[TBL] [Abstract][Full Text] [Related]
14. Divergent expression patterns for hypoxia-inducible factor-1beta and aryl hydrocarbon receptor nuclear transporter-2 in developing kidney.
Freeburg PB; Abrahamson DR
J Am Soc Nephrol; 2004 Oct; 15(10):2569-78. PubMed ID: 15466261
[TBL] [Abstract][Full Text] [Related]
15. Role of cAMP in mediating AHR signaling.
Oesch-Bartlomowicz B; Oesch F
Biochem Pharmacol; 2009 Feb; 77(4):627-41. PubMed ID: 19013136
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation by the Wilms' tumour suppressor protein WT1.
Wagner KJ; Roberts SG
Biochem Soc Trans; 2004 Dec; 32(Pt 6):932-5. PubMed ID: 15506928
[TBL] [Abstract][Full Text] [Related]
17. The WT1 Wilms' tumor suppressor gene is a downstream target for insulin-like growth factor-I (IGF-I) action in PC12 cells.
Sarfstein R; Werner H
J Neurochem; 2006 Nov; 99(3):818-26. PubMed ID: 16911581
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization and tissue distribution of aryl hydrocarbon receptor nuclear translocator isoforms, ARNT1 and ARNT2, and identification of novel splice variants in common cormorant (Phalacrocorax carbo).
Lee JS; Kim EY; Iwata H; Tanabe S
Comp Biochem Physiol C Toxicol Pharmacol; 2007 Apr; 145(3):379-93. PubMed ID: 17337252
[TBL] [Abstract][Full Text] [Related]
19. Genomic imprinting at the WT1 gene involves a novel coding transcript (AWT1) that shows deregulation in Wilms' tumours.
Dallosso AR; Hancock AL; Brown KW; Williams AC; Jackson S; Malik K
Hum Mol Genet; 2004 Feb; 13(4):405-15. PubMed ID: 14681303
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of latent transforming growth factor-beta binding protein 1 (LTBP-1) in dioxin receptor-null mouse embryo fibroblasts.
Santiago-Josefat B; Mulero-Navarro S; Dallas SL; Fernandez-Salguero PM
J Cell Sci; 2004 Feb; 117(Pt 6):849-59. PubMed ID: 14762110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
